Q3 2024 Afya Ltd Earnings Call Transcript
Key Points
- Afya Ltd (AFYA) reported a net revenue growth of over 16% year over year, reaching BRL841 million.
- Adjusted EBITDA grew by 25% year over year, with a margin of 41.4%.
- The company achieved a record cash flow from operating activities, ending the nine-month period with BRL1.168 billion, a 25% increase from the previous year.
- Afya Ltd (AFYA) successfully completed the acquisition of Unidom, adding 300 medical seats and strengthening its presence in Salvador.
- The medical practice solutions segment saw a 15% increase in net revenue year over year, driven by strong B2B and B2P engagements.
- The number of monthly active users in the digital services segment declined by 4% this quarter.
- There was a deceleration in net revenue growth for the continuing education segment this quarter.
- The competitive environment remains challenging, with increased competition potentially impacting future tuition increases.
- The transition from the PEBMED Portal to the Afya portal led to a decrease in monthly active users.
- Financial leverage remains a concern, although it has decreased, the company continues to focus on managing its debt levels.
Thank you for joining us for Afya's conference call. I'm here today with Afya's CEO, Virgilio Gibbon; and our CFO, Luis André Blanco. During today's presentation, our executives will make forward-looking statements. Forward-looking statements can be related to future events, future financial or operating performance, known and unknown risks, uncertainties, and other factors that may cause Afya's actual results to differ materially from those contemplated by these forward-looking statements.
Forward-looking statements in this presentation include, but are not limited to, statements related to the business and financial performance, expectations and guidance for future periods, or expectations regarding the company's strategic product initiatives and its related benefits.
These risks include those more fully described in our filings with the Securities and Exchange Commission. The forward-looking statements in this presentation are based on the information available to us as of the date hereof. You should not rely on them as predictions of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
